Chronic non-atrophic gastritis

Written by Si Li Li

Gastroenterology

Updated on January 23, 2025

00:00

00:00

Chronic non-atrophic gastritis is also known as chronic superficial gastritis. It is a classification of chronic gastritis, which also includes chronic atrophic gastritis and special types of gastritis as other classifications. Chronic non-atrophic gastritis refers to a condition where the glands in the gastric mucosa do not show atrophy, thus it is called chronic non-atrophic gastritis. Generally, the endoscopic appearance of the gastric mucosa being hyperemic, edematous, or eroded can lead to a diagnosis of chronic non-atrophic gastritis. Treatment mainly focuses on acid suppression, protecting the stomach, promoting gastric motility, and protecting the gastric mucosa. If there is a positive Helicobacter pylori infection, eradication treatment for Helicobacter pylori is required. Patients with chronic non-atrophic gastritis should primarily consume a light and easy-to-digest diet.

Other Voices

home-news-image

Written by Feng Ying Shuai

Traditional Chinese Medicine

1min 7sec

home-news-image

Where to apply moxibustion for atrophic gastritis?

For some symptoms of atrophic gastritis, moxibustion can be applied, such as on the Zhongwan acupoint located on the Ren meridian, as well as the Xiawan and Liangqiu acupoints. Moxibustion can also be done on the Zusanli acupoint along the stomach meridian, as well as on Neiguan and Gongsun acupoints, which are intersections of the eight meridians and can regulate atrophic gastritis. However, there is a particular method to follow during moxibustion; generally, acupoints on the upper body are treated first, followed by those on the lower body. For instance, start with the acupoints on the abdomen such as Zhongwan, Xiawan, and Liangqiu, followed by Zusanli, and then Gongsun. During moxibustion, the amount of moxa used should increase gradually, and the duration of treatment should extend from short to longer periods, indicating that the treatment period for atrophic gastritis might be longer.

home-news-image

Written by Wu Hai Wu

Gastroenterology

44sec

home-news-image

What are the symptoms before atrophic gastritis turns cancerous?

Patients with atrophic gastritis primarily exhibit symptoms such as dull pain, bloating, and burning pain in the upper abdomen, along with belching, acid reflux, weight loss, anemia, and more. If the pain from atrophic gastritis does not follow a clear pattern and is accompanied by progressive weight loss and refractory anemia, the possibility of cancerous changes in atrophic gastritis should be considered. It is advisable to promptly complete an endoscopy to confirm the diagnosis and rule out malignancy, and, if necessary, undertake a biopsy. In terms of treatment, it is first essential to test for Helicobacter pylori infection and then use medications to protect the gastric mucosa.

home-news-image

Written by Si Li Li

Gastroenterology

1min 7sec

home-news-image

Can atrophic gastritis and gastric ulcers eat sweet potatoes?

Patients with atrophic gastritis and gastric ulcers should not eat sweet potatoes. Common symptoms for patients with atrophic gastritis and gastric ulcers include upper abdominal distension and pain, belching, acid reflux, nausea, vomiting, poor appetite, indigestion, and heartburn. After a clear diagnosis, standardized medication treatment is required. Additionally, it is essential for these patients to quit smoking and drinking alcohol; they should not drink strong tea or coffee. Foods that are rich, greasy, spicy, fried, grilled, cold, sweet, along with milk, soy milk, glutinous rice, and sweet potatoes are also not recommended. For example, sweet potatoes are difficult to digest and can increase gastric acid secretion, which further irritates the gastric mucosa and aggravates these two diseases. Therefore, patients with atrophic gastritis and gastric ulcers should not eat sweet potatoes.

home-news-image

Written by Jiang Guo Ming

Gastroenterology

1min 6sec

home-news-image

What medicine should be taken for atrophic gastritis with erosion?

Chronic atrophic gastritis with erosion requires drug treatment based on the specific symptoms of the patient and whether there is a Helicobacter pylori infection. The infection rate of Helicobacter pylori is very high, often exceeding 50%, so it is also necessary to check for Helicobacter pylori infection in cases of chronic atrophic gastritis. If there is a Helicobacter pylori infection, antibacterial treatment is needed, typically employing a quadruple therapy. If there is no Helicobacter pylori infection, symptomatic treatment is generally used. Common treatments include protecting the gastric mucosa, suppressing gastric acid, and enhancing gastric motility, among others. Additionally, it is important to pay attention to daily diet and lifestyle habits, focusing on light and easy-to-digest foods, and avoiding raw, greasy, spicy, and irritating foods; quitting smoking and drinking can also be helpful. (Specific medication usage should be conducted under the guidance of a doctor.)

home-news-image

Written by Si Li Li

Gastroenterology

1min 9sec

home-news-image

Is atrophic gastritis easy to treat?

Atrophic gastritis is a type of chronic gastritis characterized by the atrophy of gastric mucosal glands. It carries a certain risk of becoming cancerous. The main symptoms include upper abdominal pain, postprandial fullness, heartburn, indigestion, belching, and acid reflux. Gastroscope examination reveals atrophy of the gastric glands, and a biopsy is needed for a pathological examination to confirm the diagnosis of chronic atrophic gastritis. In terms of treatment, the first step is to eradicate Helicobacter pylori, which includes a regimen of one proton pump inhibitor, two antibiotics, and one bismuth agent, lasting for 14 days. This is followed by acid suppression and mucosal repair treatments. Additionally, the treatment with traditional Chinese medicine plays a significant role in managing atrophic gastritis. This condition is challenging to treat, has poor outcomes, is prone to relapse, and carries a risk of cancer transformation.